T1	Outcomes 581 606	efficacy and tolerability
T2	Outcomes 1249 1263	Adverse events
T3	Outcomes 1618 1634	HCV RNA in serum
T4	Outcomes 1679 1695	HCV RNA negative
T5	Outcomes 1729 1753	Sustained response rates
T6	Outcomes 1897 1921	moderate adverse events,
T7	Outcomes 2047 2091	anaemia, neutropenia, nausea and depression,
T8	Outcomes 2271 2296	sustained response rates.